Literature DB >> 2154582

Viral T-antigen interactions with cellular proto-oncogene and anti-oncogene products.

A A Schreier1, J Gruber.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2154582     DOI: 10.1093/jnci/82.5.354

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

Review 1.  Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Authors:  J Doniger; S Muralidhar; L J Rosenthal
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  A kinase activity associated with simian virus 40 large T antigen phosphorylates upstream binding factor (UBF) and promotes formation of a stable initiation complex between UBF and SL1.

Authors:  W Zhai; L Comai
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription.

Authors:  S Muralidhar; J Doniger; E Mendelson; J C Araujo; F Kashanchi; N Azumi; J N Brady; L J Rosenthal
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice.

Authors:  L Fromm; W Shawlot; K Gunning; J S Butel; P A Overbeek
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  Transformation and immortalization of Leydig cells from the Sprague-Dawley rat by an early genetic region of simian virus 40 DNA.

Authors:  M L Nagpal; D Wang; J H Calkins; T Lin
Journal:  Cell Tissue Res       Date:  1994-03       Impact factor: 5.249

6.  Antioncogenic effect of adenovirus E1A in human tumor cells.

Authors:  S M Frisch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Unwinding of chromatin by the SV40 large T antigen DNA helicase.

Authors:  U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.